EPH98 Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study by Yan, V., Yang, Y., Wan, E.Y.F., Yiu, H.H.E., Wong, I.C.K., Chan, E.W.

Get full text

Decline in Cancer Diagnoses during the ‘Zero COVID’ Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic by Youn, H.M., Zhang, Y., Liu, A., Ng, C.S., Liang, J., Lau, G.K.K., Lee, S.F., Lok, J., Lam, C.L.K., Wan, E.Y.F., Quan, J.

Get full text

Feature tracking for assessment of diastolic function by cardiovascular magnetic resonance imaging by Ng, M.Y., Tong, X., He, J., Lin, Q., Luo, L., Chen, Y., Shen, X.P., Wan, E.Y.F., Yan, A.T., Yiu, K.H.

Get full text

Prediction models for the risk of cardiovascular diseases in Chinese patients with type 2 diabetes mellitus: a systematic review by Dong, W., Wan, E.Y.F., Bedford, L.E., Wu, T., Wong, C.K.H., Tang, E.H.M., Lam, C.L.K.

Get full text

Relation between HbA1c and incident cardiovascular disease over a period of 6 years in the Hong Kong population by Wan, E.Y.F., Yu, E.Y.T., Fung, C.S.C., Chin, W.Y., Fong, D.Y.T., Chan, A.K.C., Lam, C.L.K.

Get full text